An interventional study of iron fortified biscuits and iron fortified biscuits in Iron Deficiency and Lead Poisoning, sponsored by Swiss Federal Institute of Technology. Completed at 1 site in Switzerland. Open to participants aged 3 Years to 13 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2014-05-12.
Sponsored by Swiss Federal Institute of Technology · Not applicable, Interventional, and Health services research
In a cross-sectional study allotted by the ethical committee of the ETH Zurich, we are investigating the extent of anemia, iron deficiency and lead intoxication in young children. For this purpose an assessment of body lead burden and iron status was conducted in a cohort of individuals residing in areas of presumed high lead exposure. Associations between lead burden and iron status will be investigated in the near future (current status of the study).
In a follow-on intervention study, the effect of iron fortification with and without NaEDTA on blood lead levels in lead-exposed children will be evaluated; and the relative impact of these two strategies on child growth, motor and cognitive test performance will be compared.
This study will investigate the potential use of iron fortification to not only combat anemia but also reduce body lead burden in lead-exposed populations; it specifically investigates whether iron fortification with NaFeEDTA could have additional beneficial effects to iron alone.
Introduction Coexisting chronic lead poisoning and iron deficiency anemia (IDA) are common in urban areas in developing regions, particularly in young children. In urban Morocco, anemia affects more than 1/3rd of schoolchildren and lead exposure is high. Lead poisoning and IDA both impair cognitive development and educability and may therefore have substantial health, social and economic costs on developing countries.
Iron status alters susceptibility to gastrointestinal lead exposure; absorption of lead is sharply increased in children with IDA. IDA upregulates the divalent metal transporter trans-port protein (DMT-1) and increases lead absorption. Thus, iron fortification to reduce IDA may also reduce lead absorption and be an effective strategy to accompany environmental lead abatement. The optimal iron compound for wheat flour is currently debated, and although elemental iron compounds are commonly used, they may be only poorly absorbed in the face of inhibitory compounds found in wheat flour.
A form of chelated iron, NaFeEDTA, is a promising iron fortificant that is recommended for wheat flour fortification. It is also a lead chelator. It may be superior to other iron fortificants in its ability to reduce body lead burden, due to:
Study aims and objectives:
Study hypotheses:
The prevalence of iron deficiency and elevated blood lead will be high in children in this region.
Study design:
Our studies will be carried out in one of the four sub-economic areas, that were previously used in the baseline assessment in and near Marrakesh, Morocco (exact site still needs to be determined according to extend of lead contamination on the level of human population). Body lead burden and iron status will be determined, and associations between these examined using a cross-sectional design. For this purpose, blood and urine samples will be collected from two groups (preschool and school-aged children), residing in an area of high lead exposure.
Study design:
An 8-month intervention study in iron deficient, lead-exposed school children (n=500) will be designed to investigate whether iron fortification to reduce IDA may also reduce lead absorption and be an effective strategy to accompany environmental lead abatement.
For this purpose these children will be divided into four groups to receive a daily fortified baked snack containing either: 1) 66.4 mg NaFeEDTA ; 2) 52.2 mg Na2EDTA dehydrate; 3) 27.1 mg FeSO4 ; or 4) no fortificants.
386 studies on the registry are indexed under Iron Deficiencies; 80 are open to participants now.
This study's enrollment of 457 is above the median of 99 across 301 interventional studies indexed under Iron Deficiencies.
Browse Iron Deficiencies studies →Swiss Federal Institute of Technology is the lead sponsor of 154 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Group receives 10 mg of Fe in form of NaFeEDTA per day. wheat flour based biscuit
Dietary Supplement: iron fortified biscuits
Group receives Na2EDTA enriched biscuit
Dietary Supplement: iron fortified biscuits
Group receives 10 mg of iron as FeSo4 per day for 8 months
Dietary Supplement: iron fortified biscuits
group receives a biscuit without additional iron
Dietary Supplement: iron fortified biscuits
10 mg of iron per day for 8 months, either in the form of NaFeEDTA
10 mg of iron per day for 8 months, in the form of FeSo4
EDTA fortified biscuit on a daily basis for 8 months
control biscuit on a daily basis for 8 months
body lead burden
changes in blood lead levels over time of the intervention
Time frame: 8 months
Iron status
changes in iron status (SF,Hb, TfR) before and after intervention
Time frame: 8 months
cognitive development
changes in cognitive development (using the K ABC II) before and after intervention
Time frame: 8 months
The record gives a start of Sep 2011, a primary completion of Jun 2012 and a completion of Jun 2012. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Swiss Federal Institute of Technology →